Dasari Surendra, Wilmarth Phillip A, Reddy Ashok P, Robertson Lucinda J G, Nagalla Srinivasa R, David Larry L
Department of Pediatrics, and Department of Biochemistry and Molecular Biology, School of Medicine, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, Oregon 97239, USA.
J Proteome Res. 2009 Mar;8(3):1263-70. doi: 10.1021/pr801054w.
A robust peptide quantification method was developed where overlapping peptide isotopic distributions were fit with predicted peptide isotopic envelope mixture models (IEMMs). Application to two difficult quantitative problems was demonstrated. The first was the quantification of deamidation, where masses of isotopic peaks differ by 1 Da, and the second was (18)O labeling, where the isotopic peaks are shifted 2 and 4 Da. In both cases, peptide quantification cannot be performed by simple integration of extracted ion chromatograms, because the isotopic envelopes of mass-shifted peptides are normally not resolved. To test the methodology for quantification of deamidation, several synthetic peptides and their corresponding deamidated forms were mixed at various ratios (1:0, 1:2, 2:1, 4:1, 10:1, and 20:1) and analyzed using the IEMM method, resulting in a high correlation (R(2) = 0.96) between measured and known percentages of deamidation. The IEMM method was then incorporated into a workflow for deamidation quantification in a large-scale proteomics experiment. A series of normal (3 day, 2 year, 35 year, and 70 year) and cataractous (93 year) human lenses were analyzed using two-dimensional liquid chromatography tandem mass spectrometry, and deamidation quantities of several gammaS-crystallin peptides ([N14-Q16], N53, [Q63-Q70], and N143) were determined. Two peptides (N53 and [Q63-Q70]) had more extensive deamidation in the water-insoluble portions of normal lens samples, and deamidation at N143 was more extensive in the 93 year water-insoluble cataractous sample. The utility of the technique for analysis of (18)O-labeled peptides was examined using mixtures of labeled BSA peptides in known (16)O/(18)O ratios (10:1, 4:1, 1:1, 1:4, and 1:10). The methodology allowed for accurate measurements of ratios of (16)O/(18)O peptides over the wide range of relative abundances.
开发了一种强大的肽定量方法,该方法通过预测的肽同位素包络混合模型(IEMM)拟合重叠的肽同位素分布。展示了该方法在两个具有挑战性的定量问题中的应用。第一个问题是脱酰胺定量,其中同位素峰的质量相差1 Da,第二个问题是(18)O标记,其中同位素峰偏移2 Da和4 Da。在这两种情况下,由于质量偏移肽的同位素包络通常无法分辨,因此不能通过简单积分提取离子色谱图来进行肽定量。为了测试脱酰胺定量方法,将几种合成肽及其相应的脱酰胺形式以各种比例(1:0、1:2、2:1、4:1、10:1和20:1)混合,并使用IEMM方法进行分析,结果测得的脱酰胺百分比与已知百分比之间具有高度相关性(R(2)= 0.96)。然后将IEMM方法纳入大规模蛋白质组学实验中脱酰胺定量的工作流程。使用二维液相色谱串联质谱分析了一系列正常(3天、2年、35年和70年)和白内障(93年)人晶状体,并测定了几种γS-晶状体蛋白肽([N14-Q16]、N53、[Q63-Q70]和N143)的脱酰胺量。两种肽(N53和[Q63-Q70])在正常晶状体样品的水不溶性部分中脱酰胺更广泛,而在93年水不溶性白内障样品中N143处的脱酰胺更广泛。使用已知(16)O/(18)O比例(10:1、4:1、1:1、1:4和1:10)的标记牛血清白蛋白肽混合物检验了该技术对(18)O标记肽分析的实用性。该方法能够在广泛的相对丰度范围内准确测量(16)O/(18)O肽的比例。